Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2025-02-20 7:08 pm Sale | 2025-02-18 | 13D | CVRx, Inc. CVRX | New Enterprise Associates 10, Limited Partnership | 2,026,083 7.800% | -220,044 (-9.80%) | Filing History |
| 2025-02-06 6:49 pm Sale | 2025-02-04 | 13D | CVRx, Inc. CVRX | Cooperatieve Gilde Healthcare IV U.A. | 1,231,490 4.900% | -136,716 (-9.99%) | Filing History |
| 2025-02-06 4:46 pm Purchase | 2024-12-31 | 13G | CVRx, Inc. CVRX | Vensana Capital I GP, LLC | 1,760,734 7.200% | 11,012 (+0.63%) | Filing History |
| 2024-11-07 9:10 pm Purchase | 2024-11-05 | 13D | CVRx, Inc. CVRX | New Enterprise Associates 10, Limited Partnership | 2,246,127 9.300% | 46,656 (+2.12%) | Filing History |
| 2024-11-01 11:05 am Sale | 2024-09-30 | 13G | CVRx, Inc. CVRX | JOHNSON & JOHNSON JNJ | 4,103,430 17.000% | -5,906 (-0.14%) | Filing History |
| 2024-02-06 7:56 pm Purchase | 2023-12-31 | 13G | CVRx, Inc. CVRX | Vensana Capital I GP, LLC | 1,749,722 8.400% | 38,367 (+2.24%) | Filing History |
| 2024-02-02 4:52 pm Sale | 2023-12-31 | 13G | CVRx, Inc. CVRX | JOHNSON & JOHNSON JNJ | 4,109,336 19.200% | -237 (-0.01%) | Filing History |
| 2024-01-19 09:24 am Sale | 2024-01-17 | 13D | CVRx, Inc. CVRX | Cooperatieve Gilde Healthcare IV U.A. | 1,368,206 6.600% | -230,557 (-14.42%) | Filing History |
| 2023-12-29 08:03 am Sale | 2023-12-27 | 13D | CVRx, Inc. CVRX | Cooperatieve Gilde Healthcare IV U.A. | 1,598,763 7.700% | -232,727 (-12.71%) | Filing History |
| 2023-02-14 08:09 am Sale | 2022-12-31 | 13G | CVRx, Inc. CVRX | Soleus Capital Master Fund, L.P. | 1,014,640 4.900% | -29,400 (-2.82%) | Filing History |
| 2023-02-06 4:06 pm Unchanged | 2022-12-31 | 13G | CVRx, Inc. CVRX | GSK PLC | 1,007,583 4.900% | 0 (Unchanged) | Filing History |
| 2023-02-03 4:24 pm Purchase | 2022-12-31 | 13G | CVRx, Inc. CVRX | Vensana Capital I GP, LLC | 1,711,355 8.300% | 249,524 (+17.07%) | Filing History |
| 2022-04-29 5:01 pm Purchase | 2022-04-28 | 13G | CVRx, Inc. CVRX | Soleus Capital Master Fund, L.P. | 1,044,040 5.100% | 1,044,040 (New Position) | Filing History |
| 2022-02-10 4:39 pm Purchase | 2021-12-31 | 13G | CVRx, Inc. CVRX | Vensana Capital I GP, LLC | 1,461,831 7.200% | 1,461,831 (New Position) | Filing History |
| 2022-02-07 1:32 pm Purchase | 2021-12-31 | 13G | CVRx, Inc. CVRX | JOHNSON & JOHNSON JNJ | 4,109,573 19.600% | 4,109,573 (New Position) | Filing History |
| 2021-07-14 6:15 pm Purchase | 2021-07-02 | 13D | CVRx, Inc. CVRX | New Enterprise Associates 10, Limited Partnership | 2,199,471 11.400% | 2,199,471 (New Position) | Filing History |
| 2021-07-12 4:52 pm Purchase | 2021-07-02 | 13G | CVRx, Inc. CVRX | GSK PLC | 1,007,583 5.000% | 1,007,583 (New Position) | Filing History |
| 2021-07-12 4:06 pm Purchase | 2021-07-02 | 13D | CVRx, Inc. CVRX | Cooperatieve Gilde Healthcare IV U.A. | 1,831,490 9.000% | 1,831,490 (New Position) | Filing History |